Related Experiment Video
Updated: May 14, 2026

08:39
Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture
Kai Yu1, Jianfeng Chen2, Yu-Yi Chu3
1The University of Texas MD Anderson Cancer Center Houston, Texas United States.
Cancer Discovery
|May 13, 2026
Summary
This study maps muscle-invasive bladder cancer (MIBC) spatial organization, revealing a luminal-to-basal axis linked to tumor evolution and chemotherapy sensitivity. Understanding this spatial landscape offers new therapeutic strategies for bladder cancer.
Area of Science:
- Oncology
- Genomics
- Spatial Biology
Background:
- Muscle-invasive bladder cancer (MIBC) exhibits clinical heterogeneity not fully captured by current molecular subtypes.
- The spatial organization of tumor states and microenvironment is crucial for understanding MIBC progression and treatment response.
Purpose of the Study:
- To construct a spatial atlas of MIBC by integrating multi-omic data.
- To identify spatial axes and their association with genomic instability, transcriptional plasticity, and immune infiltration.
- To define a spatial framework for understanding therapeutic vulnerabilities in MIBC.
Main Methods:
- Integration of spatial transcriptomics from 22 MIBC tumors with matched bulk RNA and whole-exome sequencing data.
- Construction of a spatial atlas to analyze tumor heterogeneity and microenvironment.
- Pan-cohort analyses across over 3,000 tumors to validate findings.
Main Results:
- Identification of a continuous, spatially organized luminal-to-basal axis within MIBC tumors.
- Luminal states enriched for FGFR3/NECTIN4; basal-like states at invasive margins associated with EGFR signaling, EMT, and immune infiltration.
- Spatial differences in tertiary lymphoid structures and conserved FGFR3-EGFR lineage exclusivity observed.
Conclusions:
- The spatial organization of MIBC is critical for defining tumor states, immune architecture, and therapeutic vulnerabilities.
- The identified luminal-basal axis provides a framework for understanding chemotherapy sensitivity and potential therapeutic targets.
- Spatial multi-omic analysis advances our understanding of MIBC heterogeneity and treatment resistance.

